Seaport Global Advisors, LLC Crispr Therapeutics Ag Transaction History

Seaport Global Advisors, LLC

  • $30.9 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $187,924 - $351,227
4,866 Added 138.71%
8,374 $524,000
Q3 2023

Nov 14, 2023
BUY
$45.39 - $59.0 $159,228 - $206,972
3,508 New
3,508 $159,000
Q1 2022

May 16, 2022
SELL
$53.19 - $79.24 $136,325 - $203,092
-2,563 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$70.09 - $111.29 $179,640 - $285,236
2,563 New
2,563 $194,000

Others Institutions Holding CRSP

# of Institutions
489
Shares Held
57.9M
Call Options Held
1.09M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.16B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Seaport Global Advisors, LLC Portfolio

Follow Seaport Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaport Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email